RSNA 2020 MRI Preview

Road to RSNA 2020: MRI

By Kate Madden Yee, staff writer
November 11, 2020

It's no secret that 2020 has been a challenging year, as healthcare providers around the world have attempted to cope with the global pandemic caused by the SARS-CoV-2 virus. But MRI has shown its value throughout the crisis, and attendees of the virtual RSNA 2020 meeting will be sure to encounter research that highlights the modality's efficacy.

Early in the pandemic, the focus was on chest x-ray and CT for helping to diagnose COVID-19, the disease caused by SARS-CoV-2. But as the crisis continued, clinicians found that the illness manifested not only in the respiratory system but also in the brain -- in the form of loss of smell or taste, stroke, coma, agitation, delirium, dizziness, seizure, or encephalopathy -- and that MRI is an important assessment tool in this regard.

Meeting attendees are likely to hear discussion about using MRI to track any long-term effects of COVID-19, as well as how the technology can help clinicians identify good candidates for particular treatments -- and perhaps even administer the treatment -- for diseases such as Alzheimer's.

Next year will be the 20th anniversary of the death of Michael Colombini, a 6-year-old child who was struck by an oxygen canister while he was in the MRI scanner. At the virtual RSNA meeting, expect discussion of how to make the modality safer, both in technological and workflow aspects.

Read on for insights into the key role MRI continues to play in the imaging enterprise, including feedback about the modality from RSNA subcommittee chairs and other experts in the field.

In a year of pandemic, MRI perseveres
The SARS-CoV-2 virus and the disease it causes, COVID-19, have changed not only patient care and how healthcare professionals work but also how medical imaging contributes to diagnosis and management. Throughout the crisis, COVID-19 MRI has been a powerful tool for physicians on the front lines.  Discuss
Canon's MR portfolio helps deliver intelligent MR performance
The Vantage Galan 3T and Vantage Orian 1.5T MRI platforms from Canon Medical Systems USA will be featured on the company's unique, immersive virtual booth during this year's RSNA annual meeting.  Discuss
MRI at RSNA: COVID-19 and beyond
At RSNA 2020, MRI's value in coping with the pandemic will be a hot topic, with abstracts particularly focused on the modality's ability to diagnose and track the illness's neurological manifestations.  Discuss